Plasma lipid oxidation and susceptibility of low-density lipoproteins to oxidation in male patients with stable coronary artery disease

Clinical Biochemistry

Volumn 29, Issue 6, 1996, Pages 573-579

  Karmansky, Israel ^a   Shnaider, Hanan ^a   Palant, Avraham ^a   Gruener, Nachman ^a  

^a CARMEL MEDICAL CENTER   (Israel)

Author keywords

angina pectoris; atherosclerosis; conjugated dienes; coronary artery disease; LDL; oxidation; TBARS; vitamin A; vitamin E

Indexed keywords

ACETYLSALICYLIC ACID; ALKADIENE; ALPHA TOCOPHEROL; ANTIOXIDANT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; NITRATE; RETINOL; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; AGED; ANALYTIC METHOD; ANGINA PECTORIS; ARTICLE; ATHEROGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DISEASE PREDISPOSITION; DISEASE SEVERITY; HUMAN; HYPERCHOLESTEROLEMIA; LIPID OXIDATION; LIPID PEROXIDATION; MALE; PRIORITY JOURNAL;

EID: 0030561411     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(96)00072-0     Document Type: Article

References (31)

1. 1. Witztum JL. The oxidation hypothesis of atheroslerosis. Lancet 1994; 344: 793-795.
2. 2. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low density lipoprotein that increase its atherogenecity. N Engl J Med 1989; 320: 915-924.
3. 3. Avogaro P, Bon GB, Cazzolato G. Presence of a modified low density lipoprotein in humans. Arteriosclerosis 1988; 8: 79-97.
4. 4. Gebicki JM, Jurgens G, Esterbauer H. Oxidation of low-density lipoprotein in vitro. In: Sies H, Ed. Oxidative stress. Pp. 371-397. Academic Press, London and San Diego, 1992.
5. 5. Babiy AV, Gebicky JM, Sullivan DR, Willey K. Increased oxidability of plasma lipoproteins in diabetic patients can be decreased by probucol therapy and is not due to glycation. Biochem Pharmacol 1992; 43: 995-1000.
6. 6. Lavy A, Brook GJ, Dankner G, Amotz AM, Aviram M. Enhanced in vitro oxidation of plasma lipoproteins derived from hypercholesterolemic patients. Metabolism 1991; 40: 794-799.
7. 7. Stalenhoef AF, Defesche JC, Kleinveld HA, Demacker PN, Kastelein JJ. Decreased resistance against in vitro oxidation of LDL from patients with familial defective apolipoprotein B-100. Arterioscler Thromb 1994; 14: 489-493.
8. 8. Regnstrom JN, Nilsson J, Tornavall P, Landou C, Hamsten A. Susceptibility to low density lipoprotein oxidation and coronary atherosclerosis in man. Lancet 1992; 339: 1183-1186.
9. 9. Raal FJ, Areias AJ, Waisberg R, Arb M. Susceptibility of low density lipoprotein to oxidation in familial hypercholesterolemia. Atherosclerosis 1995; 115: 9-15.
10. 10. Andrews B, Burnand K, Paganga G, et al. Oxidizability of low density lipoproteins in patients with carotid or femoral artery atherosclerosis. Atherosclerosis 1995; 112: 77-84.
11. 11. Hui-chong C, Jing-Ren J, Shy-Ming S. Increased oxidizability of plasma low density lipoprotein from patients with coronary artery disease. Biochim Biophys Acta 1994; 1225: 200-208.
12. 12. Liu K, Cuddy TE, Pierce GN. Oxidative status of lipoproteins in coronary disease patients. Am Heart J 1992; 123: 285-290.
13. 13. Dubois-Rande JL, Artigou JY, Darmon JY et al. Oxidative stress in patients with unstable angina. Eur Heart J 1994; 15: 179-183.
14. 14. Miwa K, Miyagi Y, Fujita M. Susceptibility of plasma low density lipoprotein to cupric ion-induced peroxidation in patients with variant angina. J Am Coll Cardiol 1995; 26: 632-638.
15. 15. Rumsey SC, Galeano NF, Arad Y, Deckelbaum RJ. Cryopreservation with sucrose maintains normal physical and biological properties of human plasma low density lipoproteins. J Lipid Res 1992; 33: 1551-1561.
16. 16. Kleinveld HA, Demacker PNM, Stalenhoef AFH. Comparative study on the effect of low-dose viamin E and probucol on the susceptibility of LDL to oxidation and the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits. Arterioscler Thromb 1994; 14: 1386-1391.
17. 17. Havel RG, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955; 34: 1345-1353.
18. 18. Conti M, Morand PC, Levillain P, Lemonnier A. Improved fluorometric determination of malonaldehyde. Clin Chem 1991; 37/7: 1273-1275.
19. 19. Lopes-Virella M, Stone P, Eliss S, Colwell JA. Cholesterol determination in HDL separated by three different methods. Clin Chem 1977; 23: 882-884.
20. 20. Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of LDL-cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
21. 21. Hansen LG, Warwick WJ. A fluorometric micro-method for serum vitamins A and E. Am J Clin Pathol 1969; 51: 538-541.
22. 22. Shearer MJ. Vitamins. In: Lim CK, Ed. HPLC of small molecules, a practical approach. Pp. 157-219. IRL Press, Oxford and Washington, 1987.
23. 23. Dean AG, Dean JA, Burton AH, Dicker RC. EpiInfo, Version 5: a word processing, database and statistic program for epidemiology on microcomputers. USD, Incorporated, Stone Mountain, GA, 1990.
24. 24. Tribble DL. Lipoprotein oxidation in dislipidemia: insight into general mechanisms affecting lipoprotein oxidative behavior. Curr Opin Lipidology 1995; 6: 196-208.
25. 25. Kotani K, Maekawa M, Kanno T, Kondo A, Toda N, Manabe M. Distribution of immunoreactive malondialdehyde-modified low-density lipoproteins in human serum. Biochim Biophys Acta 1994; 1215: 120-125.
26. 26. Miyazawa T, Fujimoto K, Oikawa S. Determination of lipid hydroperoxides in low density lipoprotein from human plasma using high performance liquid chromatography with chemiluminescence detection. Biomed Chromatogr 1990; 4: 131-134.
27. 27. McCord JM. Oxygen-derived free radicals in postischaemic tissue injury. N Engl J Med 1985; 312: 195-163.
28. 28. Gieseg SP, Esterbauer H. Low density lipoprotein is saturable by pro-oxidant copper. FEBS Lett 1994; 343: 188-194.
29. 29. Maxwell SRJ, Wiklund O, Bondjers G. Measurement of antioxidant activity in lipoproteins using enhanced chemiluminescence. Atherosclerosis 1994; 111: 79-89.
30. 30. Jordan P, Brubachter D, Moser U, Stahelin HB, Gey KF. Vitamin E and vitamin A concentrations in plasma adjusted for cholesterol and triglycerides by multiple regression. Clin Chem 1995; 41/6: 924-927.
31. 31. Cominacini L, Garbin U, Pastorino AM et al. Predisposition to LDL oxidation in patients with and without angiographically established coronary artery disease. Atherosclerosis 1993; 99: 63-70.